NCT Immunotherapy Program

Tumor immunology is one of the most innovative areas of oncology. Many active research groups of DKFZ and of Heidelberg Medical Faculty are collaborating within the Heidelberg Immunology Network. Almost every aspect of tumor immunology is represented in this network: starting from immunodiagnostics and analysis of immune evasion mechanisms, treatment strategies such as tumor vaccination and breaking immune tolerance to development of anti-tumor antibodies to initiate  a T cell response and, in particular, reversing treatment resistance by modulating apoptotic signaling.

Immunotherapy
 

Units within the program

The Immunotherapy Program (coordinator: Prof. Dr. Peter Krammer) is closely linked with Molecular Diagnostics and Novel Therapeutics and provides information and tools for other research fields of translational therapeutic oncology.